Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
Oral Valacyclovir Option
San Francisco - A one-week course of oral valacyclovir (Valtrex) appears to be a safe, effective, and economical alternative to inpatient or outpatient intravenous (IV) acyclovir (Zovirax) for treatment of immunocompromised patients with uncomplicated, acute herpes zoster virus infections, Mathijs H. Brentjens, M.D., said at the annual meeting of the American Academy of Dermatology.
Related Videos
Related Content
